A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study

Author: Lhomme C.   Vennin P.   Callet N.   Lesimple T.   Achard J.L.   Chauvergne J.   Luporsi E.   Chinet-Charrot P.   Coudert B.   Couette J.E.   Guastalla J.P.   Lebrun D.   Ispas S.   Blumberg J.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.75, Iss.2, 1999-11, pp. : 187-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content